Research graph
References from Stress Cardiovascular Magnetic Resonance: Myocardial Perfusion Imaging. Local targets link to admitted publications; unresolved targets remain external evidence.
Safety and tolerability of regadenoson in comparison with adenosine stress cardiovascular magnetic resonance: data from a multicentre prospective registry
10.1007/s10554-021-02363-4 · 2022 · External reference
Quantitative cardiovascular magnetic resonance myocardial perfusion mapping to assess hyperaemic response to adenosine stress
10.1093/ehjci/jeaa252 · 2021 · External reference
Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography
10.1161/01.cir.99.6.763 · 1999 · External reference
Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease
10.1161/01.cir.0000080915.35024.a9 · 2003 · External reference
Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability
10.1016/s0002-9149(96)00329-3 · 1996 · External reference
Vasodilator myocardial perfusion cardiac magnetic resonance imaging is superior to dobutamine stress echocardiography in the detection of relevant coronary artery stenosis: a systematic review and meta-analysis on their diagnostic accuracy
10.3389/fcvm.2021.630846 · 2021 · External reference
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention
10.1056/nejmoa0807611 · 2009 · External reference
Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography
10.1161/01.cir.89.3.1013 · 1994 · External reference
Diagnostic accuracy of cardiac magnetic resonance versus fractional flow reserve: a systematic review and meta-analysis
10.14740/cr1028 · 2020 · External reference
Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis
2017 · External reference
Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis
10.1161/circimaging.114.002666 · 2015 · External reference
10.1016/j.jacc.2011.12.040
10.1016/j.jacc.2011.12.040 · 2012 · External reference
Diagnostic performance of CMR, SPECT, and PET imaging for the identification of coronary artery disease: a meta-analysis
2021 · External reference
Gadobutrol-enhanced cardiac magnetic resonance imaging for detection of coronary artery disease
10.1016/j.jacc.2020.07.060 · 2020 · External reference
Diagnostic and prognostic value of stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis
10.1001/jamacardio.2023.1290 · 2023 · External reference
Prognostic value of stress cardiac magnetic resonance in patients with known coronary artery disease
10.1016/j.jcmg.2021.06.025 · 2022 · External reference
Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the clinical evaluation of magnetic resonance imaging in coronary heart disease (CE-MARC) trial
10.1161/circulationaha.112.000071 · 2014 · External reference
Stress CMR in patients with obesity: insights from the stress CMR perfusion imaging in the United States (SPINS) registry
10.1093/ehjci/jeaa281 · 2021 · External reference
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial
10.1093/eurheartj/ehm617 · 2008 · External reference
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial
10.1016/s0140-6736(11)61335-4 · 2012 · External reference
Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries
10.1016/j.jcmg.2018.12.023 · 2019 · External reference
Safety and prognostic value of vasodilator stress cardiovascular magnetic resonance in patients with heart failure and reduced ejection fraction
2020 · External reference
Stress perfusion CMR in patients with known and suspected CAD: prognostic value and optimal ischemic threshold for revascularization
10.1016/j.jcmg.2017.02.006 · 2017 · External reference
Prognostic value of vasodilator stress cardiac magnetic resonance imaging: a multicenter study with 48 000 patient-years of follow-up
10.1001/jamacardio.2019.0035 · 2019 · External reference
Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain
10.1016/j.jacc.2019.07.074 · 2019 · External reference
The prognostic significance of quantitative myocardial perfusion
2020 · External reference
Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial
10.1016/j.jacc.2018.09.006 · 2018 · External reference
Insights from the NHLBI-sponsored women’s ischemia syndrome evaluation (WISE) study
10.1016/j.jacc.2004.12.084 · 2006 · External reference
Diagnostic accuracy of stress perfusion CMR for risk stratification in patients with MR-conditional pacemakers
10.1016/j.jcmg.2021.06.014 · 2021 · External reference
Long-term prognostic value of vasodilator stress cardiac magnetic resonance in patients with atrial fibrillation
10.1002/ehf2.13736 · 2022 · External reference
Quantitative myocardial perfusion predicts outcomes in patients with prior surgical revascularization
10.1016/j.jacc.2021.12.037 · 2022 · External reference
Prognostic value of vasodilator stress perfusion CMR in patients with previous coronary artery bypass graft
10.1093/ehjci/jeaa316 · 2021 · External reference
Prognostic value of stress CMR perfusion imaging in patients with reduced left ventricular function
10.1016/j.jcmg.2020.05.034 · 2020 · External reference
Magnetic resonance perfusion or fractional flow reserve in coronary disease
10.1056/nejmoa1716734 · 2019 · External reference
Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial
10.1001/jama.2016.12680 · 2016 · External reference
Initial invasive or conservative strategy for stable coronary disease
10.1056/nejmoa1915922 · 2020 · External reference
ISCHEMIA-EXTEND studies: rationale and design
10.1016/j.ahj.2022.09.009 · 2022 · External reference
Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging
10.1016/j.jcmg.2013.10.021 · 2014 · External reference
Stress perfusion cardiac magnetic resonance imaging effectively risk stratifies diabetic patients with suspected myocardial ischemia
10.1161/circimaging.115.004136 · 2016 · External reference
The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease
2013 · External reference
Prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance in patients with prior myocardial infarction
10.1016/j.jcmg.2021.04.021 · 2021 · External reference
Prognostic value of stress perfusion cardiac MRI in cardiovascular disease: a systematic review and meta-analysis of the effects of the scanner, stress agent, and analysis technique
10.1148/ryct.230382 · 2024 · External reference
The STRATEGY study (stress cardiac magnetic resonance versus computed tomography coronary angiography for the management of symptomatic revascularized patients)
2016 · External reference
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines
2021 · External reference
2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European society of cardiology (ESC)
10.1093/eurheartj/ehz425 · 2020 · External reference
Society for cardiovascular magnetic resonance perspective on the 2021 AHA/ACC chest pain guidelines
10.1186/s12968-021-00835-z · 2022 · External reference
10.1093/eurheartj/ehae177
10.1093/eurheartj/ehae177 · 2024 · External reference
The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability
10.1093/eurheartj/ehy267 · 2018 · External reference
Optimal medical therapy with or without PCI for stable coronary disease
10.1056/nejmoa070829 · 2007 · External reference
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the clinical outcomes utilizing revascularization and aggressive DruG evaluation (COURAGE) trial
10.1016/j.amjcard.2006.07.082 · 2007 · External reference
After ISCHEMIA: Is cardiac MRI a reliable gatekeeper for invasive angiography and myocardial revascularization?
10.1007/s00059-020-04936-w · 2020 · External reference
Survival after invasive or conservative management of stable coronary disease
10.1161/circulationaha.122.062714 · 2023 · External reference
Late gadolinium enhancement is a risk factor for major adverse cardiac events in unrecognised myocardial infarction without apparent symptoms: a meta-analysis
10.1016/j.crad.2020.07.038 · 2021 · External reference
Prognostic value of late gadolinium enhancement in nonischemic cardiomyopathy
10.1016/j.amjcard.2016.06.059 · 2016 · External reference
Myocarditis in relation to angiographic findings in patients with provisional diagnoses of MINOCA
10.1016/j.jcmg.2020.02.037 · 2020 · External reference
Diagnostic and prognostic role of cardiac magnetic resonance in MINOCA: systematic review and meta-analysis
10.1016/j.jcmg.2022.12.029 · 2023 · External reference
Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the “suspected CAD” cohort of the european cardiovascular magnetic resonance registry
10.1186/s12968-015-0222-1 · 2016 · External reference
Cost-effectiveness of cardiovascular magnetic resonance in diagnosing coronary artery disease in the Australian health care system
10.1016/j.hlc.2020.07.008 · 2021 · External reference
Cost-effectiveness analysis of stress cardiovascular magnetic resonance imaging for stable chest pain syndromes
10.1016/j.jcmg.2020.02.029 · 2020 · External reference
Multicenter evaluation of dynamic three-dimensional magnetic resonance myocardial perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve
10.1161/circimaging.114.003061 · 2015 · External reference
Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use
10.1016/j.ijcard.2016.04.158 · 2016 · External reference
Association of adverse clinical outcomes with peri-infarct ischemia detected by stress cardiac magnetic imaging
10.1016/j.jacc.2024.04.062 · 2024 · External reference
Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults
10.1001/2012.jama.11089 · 2012 · External reference
Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults
10.1001/2012.jama.11089 · ExternalCitation · doi-reference
Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial
10.1001/jama.2016.12680 · ExternalCitation · doi-reference
Prognostic value of vasodilator stress cardiac magnetic resonance imaging: a multicenter study with 48 000 patient-years of follow-up
10.1001/jamacardio.2019.0035 · ExternalCitation · doi-reference
Diagnostic and prognostic value of stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis
10.1001/jamacardio.2023.1290 · ExternalCitation · doi-reference
Long-term prognostic value of vasodilator stress cardiac magnetic resonance in patients with atrial fibrillation
10.1002/ehf2.13736 · ExternalCitation · doi-reference
After ISCHEMIA: Is cardiac MRI a reliable gatekeeper for invasive angiography and myocardial revascularization?
10.1007/s00059-020-04936-w · ExternalCitation · doi-reference
Safety and tolerability of regadenoson in comparison with adenosine stress cardiovascular magnetic resonance: data from a multicentre prospective registry
10.1007/s10554-021-02363-4 · ExternalCitation · doi-reference
ISCHEMIA-EXTEND studies: rationale and design
10.1016/j.ahj.2022.09.009 · ExternalCitation · doi-reference
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the clinical outcomes utilizing revascularization and aggressive DruG evaluation (COURAGE) trial
10.1016/j.amjcard.2006.07.082 · ExternalCitation · doi-reference
Prognostic value of late gadolinium enhancement in nonischemic cardiomyopathy
10.1016/j.amjcard.2016.06.059 · ExternalCitation · doi-reference
Late gadolinium enhancement is a risk factor for major adverse cardiac events in unrecognised myocardial infarction without apparent symptoms: a meta-analysis
10.1016/j.crad.2020.07.038 · ExternalCitation · doi-reference
Cost-effectiveness of cardiovascular magnetic resonance in diagnosing coronary artery disease in the Australian health care system
10.1016/j.hlc.2020.07.008 · ExternalCitation · doi-reference
Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use
10.1016/j.ijcard.2016.04.158 · ExternalCitation · doi-reference
Insights from the NHLBI-sponsored women’s ischemia syndrome evaluation (WISE) study
10.1016/j.jacc.2004.12.084 · ExternalCitation · doi-reference
10.1016/j.jacc.2011.12.040
10.1016/j.jacc.2011.12.040 · ExternalCitation · doi-reference
Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial
10.1016/j.jacc.2018.09.006 · ExternalCitation · doi-reference
Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain
10.1016/j.jacc.2019.07.074 · ExternalCitation · doi-reference
Gadobutrol-enhanced cardiac magnetic resonance imaging for detection of coronary artery disease
10.1016/j.jacc.2020.07.060 · ExternalCitation · doi-reference
Quantitative myocardial perfusion predicts outcomes in patients with prior surgical revascularization
10.1016/j.jacc.2021.12.037 · ExternalCitation · doi-reference
Association of adverse clinical outcomes with peri-infarct ischemia detected by stress cardiac magnetic imaging
10.1016/j.jacc.2024.04.062 · ExternalCitation · doi-reference
Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging
10.1016/j.jcmg.2013.10.021 · ExternalCitation · doi-reference
Stress perfusion CMR in patients with known and suspected CAD: prognostic value and optimal ischemic threshold for revascularization
10.1016/j.jcmg.2017.02.006 · ExternalCitation · doi-reference
Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries
10.1016/j.jcmg.2018.12.023 · ExternalCitation · doi-reference
Cost-effectiveness analysis of stress cardiovascular magnetic resonance imaging for stable chest pain syndromes
10.1016/j.jcmg.2020.02.029 · ExternalCitation · doi-reference
Myocarditis in relation to angiographic findings in patients with provisional diagnoses of MINOCA
10.1016/j.jcmg.2020.02.037 · ExternalCitation · doi-reference
Prognostic value of stress CMR perfusion imaging in patients with reduced left ventricular function
10.1016/j.jcmg.2020.05.034 · ExternalCitation · doi-reference
Prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance in patients with prior myocardial infarction
10.1016/j.jcmg.2021.04.021 · ExternalCitation · doi-reference
Diagnostic accuracy of stress perfusion CMR for risk stratification in patients with MR-conditional pacemakers
10.1016/j.jcmg.2021.06.014 · ExternalCitation · doi-reference
Prognostic value of stress cardiac magnetic resonance in patients with known coronary artery disease
10.1016/j.jcmg.2021.06.025 · ExternalCitation · doi-reference
Diagnostic and prognostic role of cardiac magnetic resonance in MINOCA: systematic review and meta-analysis
10.1016/j.jcmg.2022.12.029 · ExternalCitation · doi-reference
Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability
10.1016/s0002-9149(96)00329-3 · ExternalCitation · doi-reference
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial
10.1016/s0140-6736(11)61335-4 · ExternalCitation · doi-reference
Optimal medical therapy with or without PCI for stable coronary disease
10.1056/nejmoa070829 · ExternalCitation · doi-reference
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention
10.1056/nejmoa0807611 · ExternalCitation · doi-reference
Magnetic resonance perfusion or fractional flow reserve in coronary disease
10.1056/nejmoa1716734 · ExternalCitation · doi-reference
Initial invasive or conservative strategy for stable coronary disease
10.1056/nejmoa1915922 · ExternalCitation · doi-reference
Quantitative cardiovascular magnetic resonance myocardial perfusion mapping to assess hyperaemic response to adenosine stress
10.1093/ehjci/jeaa252 · ExternalCitation · doi-reference
Stress CMR in patients with obesity: insights from the stress CMR perfusion imaging in the United States (SPINS) registry
10.1093/ehjci/jeaa281 · ExternalCitation · doi-reference
Prognostic value of vasodilator stress perfusion CMR in patients with previous coronary artery bypass graft
10.1093/ehjci/jeaa316 · ExternalCitation · doi-reference
10.1093/eurheartj/ehae177
10.1093/eurheartj/ehae177 · ExternalCitation · doi-reference
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial
10.1093/eurheartj/ehm617 · ExternalCitation · doi-reference
The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability
10.1093/eurheartj/ehy267 · ExternalCitation · doi-reference
2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European society of cardiology (ESC)
10.1093/eurheartj/ehz425 · ExternalCitation · doi-reference
Prognostic value of stress perfusion cardiac MRI in cardiovascular disease: a systematic review and meta-analysis of the effects of the scanner, stress agent, and analysis technique
10.1148/ryct.230382 · ExternalCitation · doi-reference
Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease
10.1161/01.cir.0000080915.35024.a9 · ExternalCitation · doi-reference
Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography
10.1161/01.cir.89.3.1013 · ExternalCitation · doi-reference
Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography
10.1161/01.cir.99.6.763 · ExternalCitation · doi-reference
Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis
10.1161/circimaging.114.002666 · ExternalCitation · doi-reference
Multicenter evaluation of dynamic three-dimensional magnetic resonance myocardial perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve
10.1161/circimaging.114.003061 · ExternalCitation · doi-reference
Stress perfusion cardiac magnetic resonance imaging effectively risk stratifies diabetic patients with suspected myocardial ischemia
10.1161/circimaging.115.004136 · ExternalCitation · doi-reference
Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the clinical evaluation of magnetic resonance imaging in coronary heart disease (CE-MARC) trial
10.1161/circulationaha.112.000071 · ExternalCitation · doi-reference
Survival after invasive or conservative management of stable coronary disease
10.1161/circulationaha.122.062714 · ExternalCitation · doi-reference
Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the “suspected CAD” cohort of the european cardiovascular magnetic resonance registry
10.1186/s12968-015-0222-1 · ExternalCitation · doi-reference
Society for cardiovascular magnetic resonance perspective on the 2021 AHA/ACC chest pain guidelines
10.1186/s12968-021-00835-z · ExternalCitation · doi-reference
Diagnostic accuracy of cardiac magnetic resonance versus fractional flow reserve: a systematic review and meta-analysis
10.14740/cr1028 · ExternalCitation · doi-reference
Vasodilator myocardial perfusion cardiac magnetic resonance imaging is superior to dobutamine stress echocardiography in the detection of relevant coronary artery stenosis: a systematic review and meta-analysis on their diagnostic accuracy
10.3389/fcvm.2021.630846 · ExternalCitation · doi-reference
